ArticlePloS one2016

Natalizumab Affects T-Cell Phenotype in Multiple Sclerosis: Implications for JCV Reactivation.

Marco Iannetta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.